×
Hero Background

Antiandrogens Companies

ID: MRFR/HC/10678-HCR
128 Pages
Rahul Gotadki
October 2025

Antiandrogens are a class of drugs that inhibit the action or effects of male sex hormones, particularly androgens, such as testosterone and dihydrotestosterone. These drugs are used for various medical purposes, including the treatment of conditions such as prostate cancer, hirsutism, acne, and certain types of hair loss. Additionally, antiandrogens may be employed in transgender hormone therapy to help suppress masculine features in transgender women.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Antiandrogens Market

Antiandrogens Key Companies

 


Latest Antiandrogens Companies Update:

Pfizer, a leading player in the market, is actively developing next-generation antiandrogens like ODM-201 with improved efficacy and tolerability profiles.


Astellas Pharma has secured regulatory approval for Xtandi (enzalutamide) in Japan, expanding its reach in the Asia-Pacific market.


Approval of Erleada (apalutamide) by the FDA for the treatment of non-metastatic castration-resistant prostate cancer marks a significant advancement in early-stage intervention. Development of next-generation antiandrogens with improved efficacy and reduced side effects is an ongoing focus in research and development.


List of Antiandrogens Key companies in the market


  • Pfizer Inc.




  • Astellas Pharma Inc.




  • F. Hoffmann-La Roche Ltd.




  •  AstraZeneca Plc




  • Abbott Laboratories




  • Takeda Pharmaceutical Company Limited




  • OSI Pharmaceuticals, Inc.




  • Genentech Inc.




  • Bristol-Myers Squibb Company




  • Novartis AG




  • Progenics Pharmaceuticals, Inc.,




  • ALZA Corporation




  • Sanofi SA




  • GlaxoSmithKline Plc




  • Amgen Inc




  • ANI Pharmaceuticals, Inc.